203 related articles for article (PubMed ID: 11450170)
21. Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of therapeutic efficacy.
Manji HK; Chen G; Hsiao JK; Risby ED; Masana MI; Potter WZ
J Clin Psychiatry; 1996; 57 Suppl 13():34-46; discussion 47-8. PubMed ID: 8970503
[TBL] [Abstract][Full Text] [Related]
22. Glycogen synthase kinase-3: a target for novel bipolar disorder treatments.
Gould TD; Zarate CA; Manji HK
J Clin Psychiatry; 2004 Jan; 65(1):10-21. PubMed ID: 14744163
[TBL] [Abstract][Full Text] [Related]
23. A common mechanism of action for three mood-stabilizing drugs.
Williams RS; Cheng L; Mudge AW; Harwood AJ
Nature; 2002 May; 417(6886):292-5. PubMed ID: 12015604
[TBL] [Abstract][Full Text] [Related]
24. The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems.
Gilmor ML; Skelton KH; Nemeroff CB; Owens MJ
J Pharmacol Exp Ther; 2003 May; 305(2):434-9. PubMed ID: 12606697
[TBL] [Abstract][Full Text] [Related]
25. Overview of the mechanism of action of lithium in the brain: fifty-year update.
Lenox RH; Hahn CG
J Clin Psychiatry; 2000; 61 Suppl 9():5-15. PubMed ID: 10826655
[TBL] [Abstract][Full Text] [Related]
26. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder.
Einat H; Manji HK
Biol Psychiatry; 2006 Jun; 59(12):1160-71. PubMed ID: 16457783
[TBL] [Abstract][Full Text] [Related]
27. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
28. Effect of prolonged phenytoin administration on rat brain gene expression assessed by DNA microarrays.
Mariotti V; Melissari E; Amar S; Conte A; Belmaker RH; Agam G; Pellegrini S
Exp Biol Med (Maywood); 2010 Mar; 235(3):300-10. PubMed ID: 20404047
[TBL] [Abstract][Full Text] [Related]
29. Treatment of bipolar disorder: new perspectives.
Alda M; Hajek T; Calkin C; O'Donovan C
Ann Med; 2009; 41(3):186-96. PubMed ID: 18821183
[TBL] [Abstract][Full Text] [Related]
30. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
Rybakowski JK
CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
[TBL] [Abstract][Full Text] [Related]
31. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
Manji HK; Duman RS
Psychopharmacol Bull; 2001; 35(2):5-49. PubMed ID: 12397885
[TBL] [Abstract][Full Text] [Related]
32. Four mood stabilizers commonly induce FEZ1 expression in human astrocytes.
Yu Z; Ono C; Kim HB; Komatsu H; Tanabe Y; Sakae N; Nakayama KI; Matsuoka H; Sora I; Bunney WE; Tomita H
Bipolar Disord; 2011; 13(5-6):486-99. PubMed ID: 22017218
[TBL] [Abstract][Full Text] [Related]
33. Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C.
Manji HK; Lenox RH
Synapse; 1994 Jan; 16(1):11-28. PubMed ID: 8134897
[TBL] [Abstract][Full Text] [Related]
34. Valproate in bipolar disorder: 2000 onwards.
Bowden CL; Singh V
Acta Psychiatr Scand Suppl; 2005; (426):13-20. PubMed ID: 15833096
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge.
Ikonomov OC; Manji HK
Am J Psychiatry; 1999 Oct; 156(10):1506-14. PubMed ID: 10518159
[TBL] [Abstract][Full Text] [Related]
36. Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania.
Corrêa C; Amboni G; Assis LC; Martins MR; Kapczinski F; Streck EL; Quevedo J
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):887-91. PubMed ID: 17367908
[TBL] [Abstract][Full Text] [Related]
37. Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium.
Marmol F
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1761-71. PubMed ID: 18789369
[TBL] [Abstract][Full Text] [Related]
38. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders.
Bauer M; Alda M; Priller J; Young LT;
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S250-4. PubMed ID: 14677087
[TBL] [Abstract][Full Text] [Related]
39. The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters.
Di Daniel E; Cheng L; Maycox PR; Mudge AW
Mol Cell Neurosci; 2006; 32(1-2):27-36. PubMed ID: 16531065
[TBL] [Abstract][Full Text] [Related]
40. Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen.
Yildiz A; Guleryuz S; Ankerst DP; Ongür D; Renshaw PF
Arch Gen Psychiatry; 2008 Mar; 65(3):255-63. PubMed ID: 18316672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
